Millennium Management’s Kinnate Biopharma Inc. Common Stock KNTE Stock Holding History

Millennium Management’s Portfolio KNTE Stock Details KNTE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-267,355	Closed	-$711K	–	6781
2024 Q1	$711K	Sell	267,355 -297,577	-53%	-$737K	﹤0.01%	4574
2023 Q4	$1.34M	Buy	564,932 +7,674	+1%	+$13.6K	﹤0.01%	3930
2023 Q3	$780K	Sell	557,258 -344,984	-38%	-$829K	﹤0.01%	4354
2023 Q2	$2.73M	Buy	+902,242	New	+$3.48M	﹤0.01%	3206
2022 Q4	–	Sell	-78,889	Closed	-$943K	–	7234
2022 Q3	$943K	Buy	+78,889	New	+$1.03M	﹤0.01%	4395
2022 Q2	–	Sell	-13,683	Closed	-$154K	–	7679
2022 Q1	$154K	Buy	+13,683	New	+$151K	﹤0.01%	5956
2021 Q4	–	Sell	-118,734	Closed	-$2.73M	–	7542
2021 Q3	$2.73M	Buy	+118,734	New	+$2.58M	﹤0.01%	3553
2021 Q1	–	Sell	-89,796	Closed	-$3.57M	–	6617
2020 Q4	$3.57M	Buy	+89,796	New	+$3.6M	﹤0.01%	2767

Millennium Management's KNTE Position: Q2 2024 in Review

Millennium Management sold out of Kinnate Biopharma Inc. Common Stock (KNTE) in Q2 2024, closing a stake of 267,355 shares — an estimated $711K sold.

Millennium Management first reported a position in KNTE in Q4 2020 and held it in 8 quarters. The position peaked at $3.57M in Q4 2020. 0 funds tracked by Wall St. Rank hold KNTE as of Q2 2024.

Millennium Management reported no remaining Kinnate Biopharma Inc. Common Stock position as of Q2 2024 after selling out during the quarter.
Millennium Management sold 267,355 Kinnate Biopharma Inc. Common Stock shares in Q2 2024, an estimated $711K.
Millennium Management first reported a position in Kinnate Biopharma Inc. Common Stock in Q4 2020 and held it in 8 quarters.
Millennium Management's Kinnate Biopharma Inc. Common Stock position peaked at $3.57M in Q4 2020.
0 funds tracked by Wall St. Rank held Kinnate Biopharma Inc. Common Stock as of Q2 2024.

Based on Millennium Management's 13F filing for Q2 2024, filed 14 Aug 2024.